Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 5/2021

22.11.2020 | Gynecologic Endocrinology and Reproductive Medicine

Decreased expression of m6A demethylase FTO in ovarian aging

verfasst von: Xiaoyan Sun, Yigan Zhang, Yuping Hu, Junxia An, Lifei Li, Yiqing Wang, Xuehong Zhang

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

N6-methyladenosine (m6A) and demethylase fat mass and obesity-associated protein (FTO) were reported to be associated with oocyte development and maturation. But the relationship between FTO and ovarian aging was still unclear. This study was aimed at investigating the FTO expression level and the m6A content during ovarian aging.

Methods

The expression level of FTO and the content of m6A RNA methylation in human follicular fluid (FF), granulosa cells (GCs) and mouse ovary from different age groups were studied by ELISA, WB, qRT-PCR, IHC and m6A Colorimetric.

Results

Human FF ELISA quantified that the level of FTO protein decreased with age (P = 0.025). QRT-PCR results showed that the relative expression of FTO in human GCs was lower in the elderly group than in the young group (P = 0.012). FTO mRNA and protein expression levels were lower in the ovary of 32-week-old mice than in 3- and 8-week-old mice (P < 0.05). Immunohistochemistry showed FTO was relatively decreased in 32-week-old mice (P < 0.05). The m6A content in total RNA from old human GCs and ovary from 32-week-old mice was significantly higher compared with the younger ones.

Conclusions

In human FF, GCs and mouse ovary, the expression of FTO decreased while the content of m6A increased with aging. However, the inner mechanism still needs further investigation.
Literatur
1.
Zurück zum Zitat Zhang J, Chen Q, Du D et al (2019) Can ovarian aging be delayed by pharmacological strategies? Aging (Albany NY) 11:817–832CrossRef Zhang J, Chen Q, Du D et al (2019) Can ovarian aging be delayed by pharmacological strategies? Aging (Albany NY) 11:817–832CrossRef
2.
Zurück zum Zitat Liu KE (2017) Case A. No. 346-advanced reproductive age and fertility. J Obstet Gynaecol Can 39:685–695CrossRef Liu KE (2017) Case A. No. 346-advanced reproductive age and fertility. J Obstet Gynaecol Can 39:685–695CrossRef
3.
Zurück zum Zitat Li L, Wang Z (2018) Ovarian aging and osteoporosis. Adv Exp Med Biol 1086:199–215CrossRef Li L, Wang Z (2018) Ovarian aging and osteoporosis. Adv Exp Med Biol 1086:199–215CrossRef
4.
Zurück zum Zitat Quinn MM, Cedars MI (2018) Cardiovascular health and ovarian aging. Fertil Steril 110:790–793CrossRef Quinn MM, Cedars MI (2018) Cardiovascular health and ovarian aging. Fertil Steril 110:790–793CrossRef
5.
Zurück zum Zitat Laisk T, Tšuiko O, Jatsenko T et al (2019) Demographic and evolutionary trends in ovarian function and aging. Hum Reprod Update 25:34–50PubMed Laisk T, Tšuiko O, Jatsenko T et al (2019) Demographic and evolutionary trends in ovarian function and aging. Hum Reprod Update 25:34–50PubMed
7.
Zurück zum Zitat Briley SM, Jasti S, McCracken JM et al (2016) Reproductive age-associated fibrosis in the stroma of the mammalian ovary. Reproduction 152:245–260CrossRef Briley SM, Jasti S, McCracken JM et al (2016) Reproductive age-associated fibrosis in the stroma of the mammalian ovary. Reproduction 152:245–260CrossRef
8.
Zurück zum Zitat Xu X, Chen X, Zhang X et al (2017) Impaired telomere length and telomerase activity in peripheral blood leukocytes and granulosa cells in patients with biochemical primary ovarian insufficiency. Hum Reprod 32:201–207PubMed Xu X, Chen X, Zhang X et al (2017) Impaired telomere length and telomerase activity in peripheral blood leukocytes and granulosa cells in patients with biochemical primary ovarian insufficiency. Hum Reprod 32:201–207PubMed
9.
Zurück zum Zitat Frye M, Harada BT, Behm M et al (2018) RNA modifications modulate gene expression during development. Science 361:1346–1349CrossRef Frye M, Harada BT, Behm M et al (2018) RNA modifications modulate gene expression during development. Science 361:1346–1349CrossRef
10.
Zurück zum Zitat He L, Li H, Wu A et al (2019) Functions of N6-methyladenosine and its role in cancer. Mol Cancer 18:176CrossRef He L, Li H, Wu A et al (2019) Functions of N6-methyladenosine and its role in cancer. Mol Cancer 18:176CrossRef
11.
Zurück zum Zitat Batista PJ, The RNA (2017) Modification N(6)-methyladenosine and its implications in human disease. Genom Proteomics Bioinform 15:154–163CrossRef Batista PJ, The RNA (2017) Modification N(6)-methyladenosine and its implications in human disease. Genom Proteomics Bioinform 15:154–163CrossRef
12.
Zurück zum Zitat Hu Y, Ouyang Z, Sui X et al (2020) Oocyte competence is maintained by m(6)A methyltransferase KIAA1429-mediated RNA metabolism during mouse follicular development. Cell Death Differ 27:2468–2483CrossRef Hu Y, Ouyang Z, Sui X et al (2020) Oocyte competence is maintained by m(6)A methyltransferase KIAA1429-mediated RNA metabolism during mouse follicular development. Cell Death Differ 27:2468–2483CrossRef
13.
Zurück zum Zitat Sui X, Hu Y, Ren C et al (2020) METTL3-mediated m(6)A is required for murine oocyte maturation and maternal-to-zygotic transition. Cell Cycle 19:391–404CrossRef Sui X, Hu Y, Ren C et al (2020) METTL3-mediated m(6)A is required for murine oocyte maturation and maternal-to-zygotic transition. Cell Cycle 19:391–404CrossRef
14.
Zurück zum Zitat Ivanova I, Much C, Di Giacomo M et al (2017) The RNA m(6)A reader YTHDF2 is essential for the post-transcriptional regulation of the maternal transcriptome and oocyte competence. Mol Cell 67(1059–1067):e4 Ivanova I, Much C, Di Giacomo M et al (2017) The RNA m(6)A reader YTHDF2 is essential for the post-transcriptional regulation of the maternal transcriptome and oocyte competence. Mol Cell 67(1059–1067):e4
15.
Zurück zum Zitat Jia G, Fu Y, Zhao X et al (2011) N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol 7:885–887CrossRef Jia G, Fu Y, Zhao X et al (2011) N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol 7:885–887CrossRef
16.
Zurück zum Zitat Zhao X, Yang Y, Sun BF et al (2014) FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis. Cell Res 24:1403–1419CrossRef Zhao X, Yang Y, Sun BF et al (2014) FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis. Cell Res 24:1403–1419CrossRef
17.
Zurück zum Zitat Boissel S, Reish O, Proulx K et al (2009) Loss-of-function mutation in the dioxygenase-encoding FTO gene causes severe growth retardation and multiple malformations. Am J Hum Genet 85:106–111CrossRef Boissel S, Reish O, Proulx K et al (2009) Loss-of-function mutation in the dioxygenase-encoding FTO gene causes severe growth retardation and multiple malformations. Am J Hum Genet 85:106–111CrossRef
18.
Zurück zum Zitat Ding C, Zou Q, Ding J et al (2018) Increased N6-methyladenosine causes infertility is associated with FTO expression. J Cell Physiol 233:7055–7066CrossRef Ding C, Zou Q, Ding J et al (2018) Increased N6-methyladenosine causes infertility is associated with FTO expression. J Cell Physiol 233:7055–7066CrossRef
19.
Zurück zum Zitat Wang YK, Yu XX, Liu YH et al (2018) Reduced nucleic acid methylation impairs meiotic maturation and developmental potency of pig oocytes. Theriogenology 121:160–167CrossRef Wang YK, Yu XX, Liu YH et al (2018) Reduced nucleic acid methylation impairs meiotic maturation and developmental potency of pig oocytes. Theriogenology 121:160–167CrossRef
20.
Zurück zum Zitat Kasowitz SD, Ma J, Anderson SJ et al (2018) Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development. PLoS Genet 14:e1007412CrossRef Kasowitz SD, Ma J, Anderson SJ et al (2018) Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development. PLoS Genet 14:e1007412CrossRef
21.
Zurück zum Zitat Xia H, Zhong C, Wu X et al (2018) Mettl3 mutation disrupts gamete maturation and reduces fertility in Zebrafish. Genetics 208:729–743CrossRef Xia H, Zhong C, Wu X et al (2018) Mettl3 mutation disrupts gamete maturation and reduces fertility in Zebrafish. Genetics 208:729–743CrossRef
22.
Zurück zum Zitat Huang B, Ding C, Zou Q et al (2019) Cyclophosphamide regulates N6-methyladenosine and m6A RNA enzyme levels in human granulosa cells and in ovaries of a premature ovarian aging mouse model. Front Endocrinol (Lausanne) 10:415CrossRef Huang B, Ding C, Zou Q et al (2019) Cyclophosphamide regulates N6-methyladenosine and m6A RNA enzyme levels in human granulosa cells and in ovaries of a premature ovarian aging mouse model. Front Endocrinol (Lausanne) 10:415CrossRef
23.
Zurück zum Zitat Li F, Zhang C, Zhang G (2019) m6A RNA methylation controls proliferation of human glioma cells by influencing cell apoptosis. Cytogenet Genome Res 159:119–125CrossRef Li F, Zhang C, Zhang G (2019) m6A RNA methylation controls proliferation of human glioma cells by influencing cell apoptosis. Cytogenet Genome Res 159:119–125CrossRef
24.
Zurück zum Zitat Min KW, Zealy RW, Davila S et al (2018) Profiling of m6A RNA modifications identified an age-associated regulation of AGO2 mRNA stability. Aging Cell 17:e12753CrossRef Min KW, Zealy RW, Davila S et al (2018) Profiling of m6A RNA modifications identified an age-associated regulation of AGO2 mRNA stability. Aging Cell 17:e12753CrossRef
25.
Zurück zum Zitat Mathiyalagan P, Adamiak M, Mayourian J et al (2019) FTO-dependent N(6)-methyladenosine regulates cardiac function during remodeling and repair. Circulation 139:518–532CrossRef Mathiyalagan P, Adamiak M, Mayourian J et al (2019) FTO-dependent N(6)-methyladenosine regulates cardiac function during remodeling and repair. Circulation 139:518–532CrossRef
26.
Zurück zum Zitat Niu Y, Lin Z, Wan A et al (2019) RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Mol Cancer 18:46CrossRef Niu Y, Lin Z, Wan A et al (2019) RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Mol Cancer 18:46CrossRef
27.
Zurück zum Zitat Zou D, Dong L, Li C et al (2019) The m(6)A eraser FTO facilitates proliferation and migration of human cervical cancer cells. Cancer Cell Int 19:321CrossRef Zou D, Dong L, Li C et al (2019) The m(6)A eraser FTO facilitates proliferation and migration of human cervical cancer cells. Cancer Cell Int 19:321CrossRef
28.
Zurück zum Zitat Yang Y, Shen F, Huang W et al (2019) Glucose is involved in the dynamic regulation of m6A in patients with type 2 diabetes. J Clin Endocrinol Metab 104:665–673CrossRef Yang Y, Shen F, Huang W et al (2019) Glucose is involved in the dynamic regulation of m6A in patients with type 2 diabetes. J Clin Endocrinol Metab 104:665–673CrossRef
29.
Zurück zum Zitat Church C, Moir L, McMurray F et al (2010) Overexpression of Fto leads to increased food intake and results in obesity. Nat Genet 42:1086–1092CrossRef Church C, Moir L, McMurray F et al (2010) Overexpression of Fto leads to increased food intake and results in obesity. Nat Genet 42:1086–1092CrossRef
Metadaten
Titel
Decreased expression of m6A demethylase FTO in ovarian aging
verfasst von
Xiaoyan Sun
Yigan Zhang
Yuping Hu
Junxia An
Lifei Li
Yiqing Wang
Xuehong Zhang
Publikationsdatum
22.11.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 5/2021
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-020-05895-7

Weitere Artikel der Ausgabe 5/2021

Archives of Gynecology and Obstetrics 5/2021 Zur Ausgabe

Images in Obstetrics and Gynecology

A live tubal twin pregnancy

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.